Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,192 | -22,921 | -16,316 | -8,525 | -32,535 |
| Depreciation Amortization | 24 | 21 | 17 | 10 | 43 |
| Other Working Capital | 97 | -557 | -316 | -1,354 | -626 |
| Other Operating Activity | 3,742 | 2,925 | 2,043 | 1,022 | 3,784 |
| Operating Cash Flow | $-25,329 | $-20,532 | $-14,572 | $-8,847 | $-29,334 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 102 | 102 | 102 | 102 | 147 |
| Financing Cash Flow | $102 | $102 | $102 | $102 | $147 |
| Beginning Cash Position | 46,620 | 46,620 | 46,620 | 46,620 | 75,807 |
| End Cash Position | 21,393 | 26,190 | 32,150 | 37,875 | 46,620 |
| Net Cash Flow | $-25,227 | $-20,430 | $-14,470 | $-8,745 | $-29,187 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,329 | -20,532 | -14,572 | -8,847 | -29,334 |
| Free Cash Flow | -25,329 | -20,532 | -14,572 | -8,847 | -29,334 |